<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />




<title>ARID1a in UTUC</title>

<script src="site_libs/jquery-1.11.3/jquery.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/cerulean.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<script src="site_libs/jqueryui-1.11.4/jquery-ui.min.js"></script>
<link href="site_libs/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="site_libs/tocify-1.9.1/jquery.tocify.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/highlightjs-1.1/default.css" rel="stylesheet" />
<script src="site_libs/highlightjs-1.1/highlight.js"></script>
<link href="site_libs/font-awesome-4.5.0/css/font-awesome.min.css" rel="stylesheet" />

<style type="text/css">code{white-space: pre;}</style>
<style type="text/css">
  pre:not([class]) {
    background-color: white;
  }
</style>
<script type="text/javascript">
if (window.hljs && document.readyState && document.readyState === "complete") {
   window.setTimeout(function() {
      hljs.initHighlighting();
   }, 0);
}
</script>



<style type="text/css">
h1 {
  font-size: 34px;
}
h1.title {
  font-size: 38px;
}
h2 {
  font-size: 30px;
}
h3 {
  font-size: 24px;
}
h4 {
  font-size: 18px;
}
h5 {
  font-size: 16px;
}
h6 {
  font-size: 12px;
}
.table th:not([align]) {
  text-align: left;
}
</style>


</head>

<body>

<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
  height: auto;
}
.tabbed-pane {
  padding-top: 12px;
}
button.code-folding-btn:focus {
  outline: none;
}
</style>


<style type="text/css">
/* padding for bootstrap navbar */
body {
  padding-top: 51px;
  padding-bottom: 40px;
}
/* offset scroll position for anchor links (for fixed navbar)  */
.section h1 {
  padding-top: 56px;
  margin-top: -56px;
}

.section h2 {
  padding-top: 56px;
  margin-top: -56px;
}
.section h3 {
  padding-top: 56px;
  margin-top: -56px;
}
.section h4 {
  padding-top: 56px;
  margin-top: -56px;
}
.section h5 {
  padding-top: 56px;
  margin-top: -56px;
}
.section h6 {
  padding-top: 56px;
  margin-top: -56px;
}
</style>

<script>
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark it active
  menuAnchor.parent().addClass('active');

  // if it's got a parent navbar menu mark it active as well
  menuAnchor.closest('li.dropdown').addClass('active');
});
</script>


<div class="container-fluid main-container">

<!-- tabsets -->
<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});
</script>

<!-- code folding -->




<script>
$(document).ready(function ()  {

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2,h3",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_').toLowerCase();
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = true;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}


.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
  padding-left: 25px;
  text-indent: 0;
}

.tocify .list-group-item {
  border-radius: 0px;
}


</style>

<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row-fluid">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">ARID in UTUC</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="index.html">
    <span class="fa fa-home"></span>
     
  </a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Descriptive analysis
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="cohort.html">Cohort features</a>
    </li>
    <li>
      <a href="arid1a-expression.html">ARID1a expression</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Association analysis
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="association-tissue.html">ARID1a by tissue type</a>
    </li>
    <li>
      <a href="association-clinicopathologic.html">ARID1a by clinicopathologic features</a>
    </li>
    <li>
      <a href="association-outcome.html">ARID1a by outcome features</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Outcome analysis
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="outcome-regression.html">Regression models</a>
    </li>
    <li>
      <a href="outcome-survival.html">Survival curves</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.com/alcideschaux/ARID1a-UTUC">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div class="fluid-row" id="header">



<h1 class="title toc-ignore">ARID1a in UTUC</h1>

</div>


<p><strong>Title:</strong> Immunohistochemical Expression of ARID1a in Upper Tract Urothelial Carcinomas: A Tissue Microarray Study of 99 Cases</p>
<p><strong>List of authors:</strong> Sarah Karram, MD<sup>1</sup>; Sheila F. Faraj MD<sup>2</sup>; Kazutoshi Fujita MD<sup>5</sup>; Enrico Munari MD<sup>1</sup>; Ie-Ming Shih MD PhD<sup>1,3,4</sup>; Alcides Chaux MD<sup>2,6</sup>; and George J. Netto MD<sup>7</sup></p>
<p><strong>Academic affiliations:</strong> <sup>1</sup>Department of Pathology, Duke University Medical Center, Durham, NC; Department of Pathology<sup>2</sup>, Gynecologic Pathology<sup>3</sup> and Oncology<sup>4</sup>, The Johns Hopkins Medical Institutions, Baltimore, MD; <sup>5</sup>Osaka University, Urology, Osaka, Japan; <sup>6</sup>Centro para el Desarrollo de la Investigación Científica, Asunción, Paraguay; <sup>7</sup>Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL</p>
<p><strong>Last update:</strong> 2016-12-15</p>
<hr />
<div id="description" class="section level2">
<h2>Description</h2>
<p>This study evaluates the immunohistochemical expression of ARID1a in 99 cases of upper tract urothelial carcinomas (UTUC) using tissue microarrays (TMA). It also evaluates the role of ARID1a immunohistochemistry as a prognosticator of outcome in UTUC.</p>
<hr />
</div>
<div id="cohort-and-tma-construction" class="section level2">
<h2>Cohort and TMA construction</h2>
<p>The dataset includes 99 patients with nonmetastatic UTUC who underwent radical nephroureterectomy (RN) with curative intent between 1997 and 2011. Forty-six patients underwent laparoscopic RN, 53 underwent open RN while 96 underwent concomitant retroperitoneal lymphadenectomy. All sections were retrieved and reviewed by a urologic pathologist for confirmation of the original diagnosis, stage of each case according to the WHO 2004 classification, and selection of representative paraffin block for TMA construction. Two TMAs were constructed with spotted triplicate tumor samples and paired benign urothelium from each UTUC.</p>
<p>Clinicopathologic data were obtained from medical records and included patient demographics and follow-up data. Tumor progression was defined as the development of recurrence at RN site, lymph node metastasis and/or visceral metastasis. Metachronous or synchronous lower tract recurrence (e.g., bladder) was considered as bladder recurrence and not considered as tumor progression. Patients were followed-up from initial diagnosis to the appearance of the event of interest or the end of the study. Patients who did not show the event of interest by the end of the study were censored for time-to-event analyses. Primary endpoints of the study were onver mortality and cancer-related mortality. Secondary endpoint were bladder recurrence and tumor progression, as defined above.</p>
<hr />
</div>
<div id="arid1a-immunohistochemistry" class="section level2">
<h2>ARID1a immunohistochemistry</h2>
<p>Immunohistichemistry for ARID1A expression was performed on 5-micrometer TMA sections using a polyclonal rabbit anti-ARID1A antibody (HPA005456, Sigma-Aldrich, St Louis, MO). Antigen retrieval was performed by submerging the tissue sections in citrate buffer (pH 6.0) and then in a steamer for 10 minutes. The sections were then incubated with the rabbit antibody at a dilution of 1:200 at 4°C overnight. A positive reaction was detected by the EnVision+System (Dako, Carpinteria, CA). Only nuclear staining was scored and tumor stromal cells served as positive internal controls.</p>
<hr />
</div>
<div id="scoring-system" class="section level2">
<h2>Scoring system</h2>
<p>An H-score was assigned in each TMA spot as the sum of the products of the intensity (0 for negative, 1 for weakly positive, 2 for moderately positive, and 3 for strongly positive) multiplied by the extent of immunohistochemical expression (0% to 100%), obtaining a value ranging from 0 to 300. Alternatively, the percentage of positive tumor cells was also recorded, considering as “positive staining” any staining intensity.</p>
<p>As each case had multiple TMA spots, the median value of ARID1a expression (either in H-scores or percentages) was used to summarize the biomarker expression. Thus, for each case only the median ARID1a value was used for statistical analysis.</p>
<hr />
</div>
<div id="statistical-analysis" class="section level2">
<h2>Statistical analysis</h2>
<p>Data analysis was carried out in 3 steps: descriptive analysis, association analysis, and outcome analysis. Data were analyzed using R version 3.3.1 (2016-06-21) (R Foundation for Statistical Computing, Vienna, Austria). The following additional R packages were esential for data analysis: dplyr, ggplot2, ggfortify, tidyr, and knitr.</p>
<div id="descriptive-analysis" class="section level3">
<h3>Descriptive analysis</h3>
<p>Categorical variables were described using frequency tables and barplots. Numerical variables were described using measurements of central tendency and dispersion, histograms, and density plots.</p>
</div>
<div id="association-analysis" class="section level3">
<h3>Association analysis</h3>
<p>Numerical ARID1a values (i.e., H-scores and percentages) were compared between tumor and nontumor tissues, as well as considering clinicopathologic and outcome features. In this context, ARID1a values were considered as the outcome variables and the clinicopathologic and outcome features as the predictor variables. Variables were described using measurements of central tendency and dispersion, boxplots, and density plots.</p>
<p>The association was evaluated using either the <a href="https://en.wikipedia.org/wiki/Mann-Whitney_U_test">Mann-Whitney U test for the sum of ranks</a>, the <a href="https://en.wikipedia.org/wiki/Wilcoxon_signed-rank_test">Wilcoxon signed rank test</a>, or the <a href="https://en.wikipedia.org/wiki/Kruskal-Wallis_one-way_analysis_of_variance">Kruskal-Wallis rank sum test</a>, depending on the features of the predictor variables.</p>
</div>
<div id="outcome-analysis" class="section level3">
<h3>Outcome analysis</h3>
<p>The outcome analysis included regression modeling and time-to-event (survival) analysis. For regression models, the ARID1a expression was categorized in low or high expression based on 6 different approaches:</p>
<ul>
<li>H-scores = 0 vs. H-score &gt; 0</li>
<li>H-scores &lt; median vs. H-score &gt; median</li>
<li>H-score &lt; upper quartile vs. H-score &gt; upper quartile</li>
<li>% positive cells = 0 vs. % positive cells &gt; 0</li>
<li>% positive cells &lt; median vs. % positive cells &gt; median</li>
<li>% positive cells &lt; upper quartile vs. % positive cells &gt; upper quartile</li>
</ul>
<p>Odds ratios were estimated using unconditional binary <a href="https://en.wikipedia.org/wiki/Logistic_regression">logistic regression</a>. Hazard ratios were estimated using <a href="https://en.wikipedia.org/wiki/Proportional_hazards_model">Cox’s proportional hazards regression</a>. Survival curves were built using the <a href="https://en.wikipedia.org/wiki/Kaplan-Meier_estimator">Kapplan-Meier estimator</a> and compared using the <a href="https://en.wikipedia.org/wiki/Log-rank_test">log-rank test</a>.</p>
<p>For overall and cancer-related mortality (primary endpoints), total follow-up time was used, even if bladder recurrence or tumor progression had appeared before. For bladder recurrence and tumor progression (secondary endpoints), time to first progression event was used, even if the patient was followed-up for a longer period of time.</p>
</div>
</div>



</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
